Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03419559
Title Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) Alone and In Combo With Durvalumab in Non-Small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Iovance Biotherapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Diego, Moores Cancer Center La Jolla California 92093 United States Details
University of California, Los Angeles, Santa Monica Hematology/Oncology Los Angeles California 90095 United States Details
University of Louisville James Graham Brown Cancer Center Louisville Kentucky 40202 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Morristown Medical Center Atlantic Hematology Oncology Morristown New Jersey 07960 United States Details
UPMC Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
University of Washington Medical Center Seattle Washington 98195-0001 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field